Contact – +1-276-477-5910
 Email – [email protected]

Home >> Latest Reports

 LATEST REPORTS


North America Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), Product, Raw Material, Pharmaceutical Dosage Form, Drug Delivery Mode, End User, and Count...

North America pharmaceutical packaging market is expected to grow by 6.4% annually in the forecast period and reach $41.88 billion by 2027 owing to the increase in healthcare coverage, growing aging population, an increase in non-communicable disease, new drug development and government initiatives ...

 44407 |  Healthcare and Social Assistance


Global Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), Product, Raw Material, Pharmaceutical Dosage Form, Drug Delivery Mode, End User, and Region: Tren...

Global pharmaceutical packaging market will reach $151.08 billion by 2027, growing by 6.8% annually over 2020-2027 owing to the increase in healthcare coverage, growing aging population, an increase in non-communicable disease, new drug development and government initiatives to promote innovations i...

 44407 |  Healthcare and Social Assistance


Asia Pacific Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country:...

Asia Pacific organ-on-chip market will grow by 35.1% annually with a total addressable market cap of $399.4 million over 2021-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative...

 44407 |  Healthcare and Social Assistance


Europe Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend...

Europe organ-on-chip market accounted for $6.9 million in 2020 and will grow by 32.2% annually over 2020-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, t...

 44407 |  Healthcare and Social Assistance


North America Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country...

North America organ-on-chip market is expected to grow by 33.7% annually in the forecast period and reach $178.6 million by 2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative t...

 44407 |  Healthcare and Social Assistance


Global Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Region: Trend ...

Global organ-on-chip market will reach $420.6 million by 2030, growing by 33.5% annually over 2020-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the sig...

 44407 |  Healthcare and Social Assistance


Asia Pacific Multiple Sclerosis Drugs Market 2020-2027 by Drug Type (Immunomodulators, Immunosuppressants), Drug Class, Drug Category (Large-molecule, Small-molecule), Route of Administration (Oral, P...

Asia Pacific multiple sclerosis drugs market will grow by 6.5% annually with a total addressable market cap of $33.56 billion over 2120-2027 owing to the growing prevalence of multiple sclerosis (MS), the rise in funding for multiple sclerosis research, and increasing approvals of novel MS drugs. H...

 44407 |  Healthcare and Social Assistance


Europe Multiple Sclerosis Drugs Market 2020-2027 by Drug Type (Immunomodulators, Immunosuppressants), Drug Class, Drug Category (Large-molecule, Small-molecule), Route of Administration (Oral, Parente...

Europe multiple sclerosis drugs market accounted for $5,668.0 million in 2020 and will grow by 4.2% annually over 2020-2027 owing to the growing prevalence of multiple sclerosis (MS), the rise in funding for multiple sclerosis research, and increasing approvals of novel MS drugs. Highlighted with 3...

 44407 |  Healthcare and Social Assistance


North America Multiple Sclerosis Drugs Market 2020-2027 by Drug Type (Immunomodulators, Immunosuppressants), Drug Class, Drug Category (Large-molecule, Small-molecule), Route of Administration (Oral, ...

North America multiple sclerosis drugs market is expected to grow by 3.8% annually in the forecast period and reach $15.65 billion by 2027 owing to the growing prevalence of multiple sclerosis (MS), the rise in funding for multiple sclerosis research, and increasing approvals of novel MS drugs. Hig...

 44407 |  Healthcare and Social Assistance


Global Multiple Sclerosis Drugs Market 2020-2027 by Drug Type (Immunomodulators, Immunosuppressants), Drug Class, Drug Category (Large-molecule, Small-molecule), Route of Administration (Oral, Parente...

Global multiple sclerosis drugs market will reach $29.97 billion by 2027, growing by 4.3% annually over 2020-2027 owing to the growing prevalence of multiple sclerosis (MS), the rise in funding for multiple sclerosis research, and increasing approvals of novel MS drugs. Highlighted with 87 tables a...

 44407 |  Healthcare and Social Assistance


x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT